Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Kramer

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Oncology|October 6, 2016
Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'Maurie Markman, Kim Kramer, Ricardo H Alvarez, et al.
Annals of Surgical Oncology|July 23, 2014
Initial experience with genomic profiling of heavily pretreated breast cancersEdgar D Staren, Donald Braun, Bradford Tan, et al.
JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primatesMatthias Miederer, Michael R McDevitt, George Sgouros, et al.
Oncoimmunology|June 27, 2013
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-<i>D</i>-glucan: A Phase I study in patients with chemoresistant neuroblastomaShakeel Modak, Brian H Kushner, Kim Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remissionBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
Pediatric Dermatology|March 3, 2009
Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosisOren J Becher, Mark Souweidane, Ehud Lavi, et al.
Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastomaBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Oncology|October 6, 2016
Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'Maurie Markman, Kim Kramer, Ricardo H Alvarez, et al.
Annals of Surgical Oncology|July 23, 2014
Initial experience with genomic profiling of heavily pretreated breast cancersEdgar D Staren, Donald Braun, Bradford Tan, et al.
JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primatesMatthias Miederer, Michael R McDevitt, George Sgouros, et al.
Oncoimmunology|June 27, 2013
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-<i>D</i>-glucan: A Phase I study in patients with chemoresistant neuroblastomaShakeel Modak, Brian H Kushner, Kim Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remissionBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastomaIrene Y Cheung, M Serena Lo Piccolo, Brian H Kushner, et al.
Pediatric Dermatology|March 3, 2009
Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosisOren J Becher, Mark Souweidane, Ehud Lavi, et al.
Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastomaBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Pageof 11